Here are several important reminders about the fungal meningitis outbreak from the American Society of Anesthesiologists.
Anesthesia
Researchers at Boston Children's Hospital and the Massachusetts Institute of Technology are testing ways to delay the rise of neuropathic pain through an anesthetic derived from shellfish toxin, according to News-Medical.
Teleflex, a medical device provider, announced its Rusch EZ-Blocker Disposable Endobronchial Blocker has received FDA premarket clearance.
The FDA is recommending healthcare professionals not use any products by the New England Compounding Center in Framingham, Mass., due to potentially contaminated medication causing a fungal meningitis outbreak, according to the American Society of Anesthesiologists.
Lighter anesthesia does not improve mortality rates of noncardiac surgery patients, according to a study reported by Anesthesiology News and featured on North American Partners in Anesthesia's facebook page.
CBIZ has acquired the assets of ProMedical, an anesthesia billing company based in Ocala, Fla.
The New York Times recently reported that hospital executives are receptive to the Obama administration’s idea to have consumers report medical mistakes and unsafe practices, but several physician lawmakers expressed concern for the proposed policy, according to the American Society…
The anesthetic drug ketamine has been found to significantly inhibit the inflammatory response to surgery, according to the Anesthesia & Analgesia.
The U.S. Department of Health and Human Services Office of the Inspector General will be reviewing payments for personally performed anesthesia services for the fiscal year 2013, according to the American Society of Anesthesiologists.
Anesthesia providers in surgery centers should be involved in efforts to realize cost savings while maintaining a high level of quality.
